Liang Jiangshui, Yin Guilin, Dong Yongqiang, Ma Zhongsha, Xiao Yuehua, Ji Tao
Diagnosis and Treatment Center of Thoracic and Lung Cancers, the First People's Hospital of Chenzhou City, Chenzhou 423000, China.
Email:
Zhonghua Zhong Liu Za Zhi. 2015 Jul;37(7):485-9.
To investigate the inhibitory effect of classic demethylating drug 5-aza-2'-deoxycytidine (5-Aza-CdR) on the growth of human lung adenocarcinoma cells in nude mouse xenograft models, and to observe its effect on methylation status and expression of TFPI-2 gene in the nude mouse xenograft tissues.
The nude mouse xenograft model was established by subcutaneous inoculation of human lung adenocarcinoma A549 cells. According to different doses of 5-Aza-CdR, the tumor-bearing nude mice were randomly divided into experimental groups (0.5 mg/kg group, 1 mg/kg group, 2 mg/kg group) and control group (0 mg/kg group). The tumor growth in the nude mice was observed. The methylation status and the expression of TFPI-2 gene mRNA and protein were detected by methylation specific polymerase chain reaction, real-time fluorescent quantitative polymerase chain reaction and Western blot assay.
The nude mice were euthanized at 28 days after intraperitoneal injection of 5-Aza-CdR. The body weight of tumor-bearing nude mice was (27.12 ± 0.38) g in the 0 mg/kg group, (26.80 ± 0.18) g in the 0.5 mg/kg group, (26.67 ± 0.28) g in the 1 mg/kg group, and (26.50 ± 0.26) g in the 2 mg/kg group, showing no significant difference among them (P > 0.05). The volume of xenograft tumors in the 0 mg/kg group was (709.22 ± 2.87)mm³, (400.67 ± 2.68)mm³ in the 0.5 mg/kg group, (285.71 ± 2.91)mm³ in the 1 mg/kg group, and (230.44 ± 3.15)mm³ in the 2 mg/kg group, showing a significant difference (P < 0.05). There were complete methylation of TFPI-2 gene in the 0 mg/kg group, incomplete methylation in the 0.5 and 1 mg/kg groups, and unmethylation in the 2 mg/kg group. The relative mRNA level in the 0, 0.5, 1, 2 mg/kg groups were 1.00 ± 0.00, 1.67 ± 0.07, 3.40 ± 0.24, and 5.55 ± 0.61, respectively (P < 0.05). The relative expression level of TFPI-2 protein in the 0, 0.5, 1, 2 mg/kg groups was 0.18 ± 0.02, 0.36 ± 0.01, 0.64 ± 0.02, and 0.81 ± 0.20, respectively (P < 0.05).
5-Aza-CdR suppresses the tumor growth of human lung adenocarcinoma cells in nude mouse xenograft models, and induces expression of TFPI-2 gene in the xenograft tumor cells. The mechanism might be that 5-Aza-CdR induces re-expression of demethylated TFPI-2 gene by demethylation, and thus inhibits the growth and proliferation of human lung adenocarcinoma cells.
探讨经典去甲基化药物5-氮杂-2'-脱氧胞苷(5-Aza-CdR)对人肺腺癌细胞裸鼠移植瘤模型生长的抑制作用,并观察其对裸鼠移植瘤组织中TFPI-2基因甲基化状态及表达的影响。
通过皮下接种人肺腺癌A549细胞建立裸鼠移植瘤模型。根据5-Aza-CdR不同剂量,将荷瘤裸鼠随机分为实验组(0.5mg/kg组、1mg/kg组、2mg/kg组)和对照组(0mg/kg组)。观察裸鼠肿瘤生长情况。采用甲基化特异性聚合酶链反应、实时荧光定量聚合酶链反应及蛋白质免疫印迹法检测TFPI-2基因的甲基化状态、mRNA及蛋白表达。
腹腔注射5-Aza-CdR后28天处死裸鼠。0mg/kg组荷瘤裸鼠体重为(27.12±0.38)g,0.5mg/kg组为(26.80±0.18)g,1mg/kg组为(26.67±0.28)g,2mg/kg组为(26.50±0.26)g,各组间差异无统计学意义(P>0.05)。0mg/kg组移植瘤体积为(709.22±2.87)mm³,0.5mg/kg组为(400.67±2.68)mm³,1mg/kg组为(285.71±2.91)mm³,2mg/kg组为(230.44±3.15)mm³,差异有统计学意义(P<0.05)。0mg/kg组TFPI-2基因呈完全甲基化,0.5mg/kg组和1mg/kg组呈不完全甲基化,2mg/kg组呈去甲基化。0、0.5、1、2mg/kg组TFPI-2基因相对mRNA水平分别为1.00±0.00、1.67±0.07、3.40±0.24、5.55±0.61,差异有统计学意义(P<0.05)。0、0.5、1、2mg/kg组TFPI-2蛋白相对表达水平分别为0.18±0.02、0.36±0.01、0.64±0.02、0.81±0.20,差异有统计学意义(P<0.05)。
5-Aza-CdR可抑制人肺腺癌细胞裸鼠移植瘤的生长,并诱导移植瘤细胞中TFPI-2基因表达。其机制可能是5-Aza-CdR通过去甲基化诱导去甲基化的TFPI-2基因重新表达,从而抑制人肺腺癌细胞的生长和增殖。